Literature DB >> 10799841

Control of gastrointestinal nematodes in first season grazing calves by two strategic treatments with eprinomectin.

P Dorny1, D Demeulenaere, K Smets, J Vercruysse.   

Abstract

A study was carried out to evaluate the effects of strategic early-season treatments with eprinomectin on first-season grazing calves exposed to strongyle infections on a naturally contaminated pasture. Two groups of first grazing season (FGS) calves were turned out in mid-May on two plots that were similar with respect to size and herbage infectivity. They grazed separately until housing at the end of October. One of these groups was given eprinomectin pour-on at turnout and 8 weeks later, while the other group served as untreated controls. The results showed that the treatments reduced gastrointestinal strongyle infections throughout the season as evidenced by lower faecal egg counts and serum pepsinogen levels compared with the controls. Furthermore, the results of herbage larval counts and postmortem worm counts in tracer animals demonstrated that the treatment had reduced herbage infectivity on the 'treated' plot. Finally, the chemoprophylactically treated calves had a better weight gain over the duration of the study than the untreated controls.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799841     DOI: 10.1016/s0304-4017(00)00220-x

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

1.  Resistance to ivermectin and the effect of topical eprinomectin on faecal egg counts in St Croix white hair sheep.

Authors:  E Panitz; R W Godfrey; R E Dodson
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

2.  Effects of chicory/perennial ryegrass swards compared with perennial ryegrass swards on the performance and carcass quality of grazing beef steers.

Authors:  Christina L Marley; Rhun Fychan; John W Davies; Nigel D Scollan; R Ian Richardson; Vince J Theobald; Elizabeth Genever; Andy B Forbes; Ruth Sanderson
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.